Importance of Apoptotic Mechanisms in Inflammatory Infiltrate of Oral Lichen Planus Lesions
Background: Oral lichen planus (OLP) is an autoimmune disease produced by T lymphocyte attack on basal epithelial cells. OLP can undergo malignant transformation that may be linked to an increased proliferative activity and decreased apoptosis rate of the epithelial cells, phenomena that may be infl...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2006-01, Vol.26 (1A), p.357-362 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Oral lichen planus (OLP) is an autoimmune disease produced by T lymphocyte attack on basal epithelial cells. OLP
can undergo malignant transformation that may be linked to an increased proliferative activity and decreased apoptosis rate
of the epithelial cells, phenomena that may be influenced by the inflammatory infiltrate. The objectives of this study were
to assess the quantitative importance of apoptosis in the inflammatory infiltrate of OLP and to discuss its influence on the
persistence of this infiltrate and on the malignant transformation of this disease. Materials and Methods: In 32 patients
with OLP and 20 controls, apoptosis was studied by TUNEL assay and caspase-3 determination, while cell cycle arrest and senescence
were studied by measurement of p21 expression. Results: There was a low frequency of lymphocytic apoptosis according to both
TUNEL (34.5% of cases negative, 65.5% with mild expression) and caspase-3 expression (42.9% of cases negative, 50% with mild
expression) findings. P21 expression was also negative (9.7% of cases) or mild (80.6% of cases) in most cases. Conclusion:
The absence or low rate of apoptosis observed in inflammatory cells in OLP appears to contribute to the persistence of the
inflammatory infiltrate, potentiating the onset of molecular disorders in epithelial cells and favouring cancer development. |
---|---|
ISSN: | 0250-7005 1791-7530 |